Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B...
Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells
About this item
Full title
Author / Creator
Publisher
England: BioMed Central Ltd
Journal title
Language
English
Formats
Publication information
Publisher
England: BioMed Central Ltd
Subjects
More information
Scope and Contents
Contents
To clarify the effect of human umbilical cord-derived mesenchymal stem cell (hUC-MSCs) treatment on colitis and to explore the role of CD5(+) B cells in MSC therapy.
The trinitrobenzenesulfonic acid (TNBS)-induced colitis mouse model was used. HUC-MSCs were transferred peritoneally. Survival rates, colitis symptoms, and macroscopic and histologi...
Alternative Titles
Full title
Human umbilical cord-derived mesenchymal stem cells protect against experimental colitis via CD5+ B regulatory cells
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_doaj_primary_oai_doaj_org_article_cb5814e152fd4b44af79fba27a72780f
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_cb5814e152fd4b44af79fba27a72780f
Other Identifiers
ISSN
1757-6512
E-ISSN
1757-6512
DOI
10.1186/s13287-016-0376-2
